Electroconvulsive therapy, depression, and cognitive outcomes: an Australian audit

The Journal of ECT
Laura J FisherDavid J McCleave

Abstract

We sought to compare cognitive and other outcomes of 2 groups of mood disorder patients, those who received ECT and those who did not, from 2 private South Australian hospitals during a 12-month period. Patients were assessed at admission and discharge from hospital on 2 validated instruments: the Health of the Nation Outcome Scales (HoNOS) and an abbreviated version of the Short-Form 36-item Health Status Questionnaire (SF-36). Patient scores on the majority of subscales of both the HoNOS and SF-36 indicated a positive response to either ECT or non-ECT. There was no significant difference in HoNOS depression score between the ECT and non-ECT groups upon discharge, despite the ECT group being significantly more depressed at admission. Cognitive functioning of those who received ECT did not change significantly from admission to discharge. However, they did not share the significant improvement in cognitive functioning of those depressed persons who had non-ECT treatment. ECT treatment of depression was not associated with a deterioration of cognitive functioning.

References

Mar 1, 1996·Biological Psychiatry·E A ColemanB J Moody
Jan 20, 1998·The American Journal of Psychiatry·C Salzman
Jun 6, 2000·Archives of General Psychiatry·S H LisanbyH A Sackeim
Jun 27, 2000·The Journal of ECT·H A Sackeim
Nov 7, 2000·Quality in Health Care : QHC·R McClellandB Bell
Oct 2, 2001·Journal of Affective Disorders·H BrodatyC Mason
Oct 24, 2002·The Journal of ECT·W Vaughn McCall
Jan 22, 2003·The Australian and New Zealand Journal of Psychiatry·Leslie Frank KoopowitzMiriam Blashki
Jun 21, 2003·BMJ : British Medical Journal·Diana RoseJonathan Bindman

❮ Previous
Next ❯

Citations

Aug 19, 2010·International Psychogeriatrics·Maria I LapidTeresa A Rummans
Jan 18, 2006·Journal of Affective Disorders·W Vaughn McCallHarold Sackeim
Mar 3, 2012·Journal of Affective Disorders·Søren Dinesen ØstergaardPer Bech
Feb 21, 2018·The Journal of ECT·Peter GiacobbeJonathan Downar
Apr 25, 2006·The Journal of ECT·Peter B RosenquistW Vaughn McCall
May 21, 2009·The Journal of ECT·Paula Barros Antunes, Marcelo P Fleck
Jul 1, 2009·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Paula Barros AntunesMarcelo P Fleck
Jun 14, 2019·The Journal of ECT·Arulmathy Arunachalam, Shanthi Sarma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Nervous and Mental Disease
P CaseyE Butler
The British Journal of Psychiatry : the Journal of Mental Science
Tom TrauerJ Smith
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
Benjamin Duke
© 2021 Meta ULC. All rights reserved